Adriforant
- Generic Name
- Adriforant
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C13H22N6
- CAS Number
- 943057-12-3
- Unique Ingredient Identifier
- D65H9YE9VU
- Background
Adriforant is under investigation in clinical trial NCT00992342 (A Phase 1 Study To Evaluate The Safety And Tolerability Of Different Doses Of PF-03893787 In Healthy Adult Volunteers).
- Associated Conditions
- -
- Associated Therapies
- -
A Phase 1 Study To Evaluate The Safety And Tolerability Of Different Doses Of PF-03893787 In Healthy Adult Volunteers
- First Posted Date
- 2009-10-09
- Last Posted Date
- 2010-03-18
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 36
- Registration Number
- NCT00992342
- Locations
- 🇧🇪
Pfizer Investigational Site, Bruxelles, Belgium
A Study To Assess The Effect Of PF-03893787 On Lung Function Following An Allergen Challenge In Asthmatic Subjects
- First Posted Date
- 2009-03-06
- Last Posted Date
- 2010-01-22
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 12
- Registration Number
- NCT00856687
- Locations
- 🇬🇧
Pfizer Investigational Site, Harrow, Middlesex, United Kingdom
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath